Unlock Advanced Bioconjugation with SMPH Crosslinker
Discover the power of N-Succinimidyl 6-(3-Maleimidopropionamido) Hexanoate (SMPH) for precise protein labeling and sophisticated bioconjugation strategies. As a leading supplier in China, we provide high-quality crosslinking reagents to accelerate your research.
Get a Quote & SampleProduct Core Value
N-Succinimidyl 6-(3-Maleimidopropionamido) Hexanoate
As a trusted manufacturer in China, we offer N-Succinimidyl 6-(3-Maleimidopropionamido) Hexanoate, a critical reagent for advanced biochemical applications. Its unique heterobifunctional nature, combining a maleimide group reactive towards thiols and an NHS ester reactive towards amines, makes it an indispensable tool for creating stable conjugates and enabling sophisticated bioconjugation chemistry.
- Precisely conjugate biomolecules using this potent maleimide NHS ester crosslinker. Our commitment as a reliable supplier ensures the quality needed for your experiments.
- Achieve targeted drug delivery with our SMPH crosslinker applications, facilitating the development of next-generation therapeutics.
- Enhance protein labeling strategies with this versatile reagent, crucial for understanding biological processes and developing diagnostics.
- Leverage our expertise as a manufacturer in China for antibody-drug conjugate synthesis, ensuring the efficient linkage of antibodies to payloads.
Key Advantages Offered
Versatile Reactivity
The dual functionality of maleimide and NHS ester groups allows for selective coupling to thiols and amines, respectively, making it a cornerstone for effective bioconjugation chemistry.
Optimal Spacer Arm
With a 14.3 Angstrom spacer arm, this crosslinker provides adequate distance between coupled molecules, preventing steric hindrance and ensuring functionality.
Enhanced Stability
Forming stable thioether bonds with thiols, this crosslinker ensures the integrity of your conjugates during handling and application, crucial for reliable results.
Key Applications
Protein Labeling
Utilize this reagent for precise protein labeling, a fundamental step in understanding protein function and developing diagnostic tools, leveraging its capabilities in protein modification techniques.
Antibody-Drug Conjugates (ADCs)
Essential for antibody-drug conjugate development, enabling the precise attachment of cytotoxic agents to antibodies for targeted cancer therapy.
Targeted Drug Delivery
Design advanced targeted drug delivery systems by conjugating therapeutic molecules to targeting moieties, enhancing treatment efficacy and reducing side effects.
Bioconjugation Strategies
Implement sophisticated bioconjugation strategies for creating novel biomolecular constructs, essential for both research and therapeutic development.